| Clinical data | |
|---|---|
| Other names | Butoxamine |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C15H25NO3 |
| Molar mass | 267.369 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Butaxamine (INN; also known asbutoxamine) is aβ2-selectivebeta blocker.[1][2] Its primary use is in experimental situations in which blockade ofβ2 receptors is necessary to determine theactivity of the drug (i.e. if the β2 receptor is completely blocked, but the given effect is still present, the given effect is not a characteristic of the β2 receptor). It has no clinical use. An alternative name is α-(1-[tert-butylamino]ethyl)-2,5-dimethoxybenzyl alcohol.
Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |